Sample Size Re-Estimation for Adaptive Sequential Design in Clinical Trials

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.18, Iss.6, 2008-11, pp. : 1184-1196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Seamless Phase II/III Design with Sample-Size Re-Estimation

By Bischoff Wolfgang

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 595-609

Taylor & Francis Ltd

Access to resources Recommend Favorite

On Cost Effectiveness and Sample Size in Clinical Trials

By Augustinus A.M. Hart Marcel G.W. Dijkgraaf

PharmacoEconomics, Vol. 22, Iss. 10, 2004-01 ,pp. : 685-688

Adis International

Access to resources Recommend Favorite

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

Adaptive Group Sequential Test for Clinical Trials with Changing Patient Population

By Feng Huaibao

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1227-1238

Taylor & Francis Ltd

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite